Aug 26 Mithra Pharmaceuticals SA :

* European Journal of Contraception and Reproductive HealthCare publishes two scientific articles about E4 (estetrol) DinoxPhase II study

* Results show E4-containing combinations havelimited effect on liver function, lipid metabolism, and bone andgrowth endocrine parameters

* Results show that combined with progestin, E4 adequatelysuppresses ovarian activity, particularly when given atdosage above 10mg/day

Source text: bit.ly/1EjaTV4Further company coverage: (Gdynia Newsroom:)